Please provide your email address to receive an email when new articles are posted on . T-cell receptors in the hearts of patients with immunotherapy-induced myocarditis differed from those in ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved trastuzumab deruxtecan for a new breast cancer indication. The approval applies to patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers identified two microRNA that may help ...

Please provide your email address to receive an email when new articles are posted on . The guide offers tools to improve communication, pain management and caregiver burden for Black patients ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations ...

Older adults who participated in time-restricted fasting by skipping breakfast were not at reduced risk for glaucoma compared ...

Please provide your email address to receive an email when new articles are posted on . Patients who received glucarpidase for acute kidney injury from methotrexate treatment had improved kidney ...

The addition of lenvatinib and pembrolizumab to chemotherapy did not extend OS for certain patients with advanced gastroesophageal adenocarcinoma, according to the agents’ manufacturers.

Please provide your email address to receive an email when new articles are posted on . A trial to assess whether smartwatch technology can detect lymphedema earlier will enroll 35 patients.

In a small cohort of adults in South Korea, the presence of cerebral small vessel disease was associated with color reading ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...